ScinoPharm Taiwan, Ltd. (TPE:1789)
Taiwan
· Delayed Price · Currency is TWD 23.10
+0.25 (1.09%)
Feb 27, 2025, 1:30 PM CST
ScinoPharm Taiwan Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 4,166 | 3,942 | 4,295 | 4,081 | 4,055 | Upgrade
|
| Cash & Short-Term Investments | 4,166 | 3,942 | 4,295 | 4,081 | 4,055 | Upgrade
|
| Cash Growth | 5.69% | -8.22% | 5.24% | 0.64% | 16.62% | Upgrade
|
| Accounts Receivable | 604.22 | 788.22 | 635.26 | 360.25 | 386.51 | Upgrade
|
| Other Receivables | 20.57 | 25.23 | 18.28 | 32.8 | 86.43 | Upgrade
|
| Receivables | 624.79 | 813.45 | 653.55 | 393.04 | 472.93 | Upgrade
|
| Inventory | 1,673 | 1,512 | 1,189 | 1,345 | 1,246 | Upgrade
|
| Prepaid Expenses | 114.91 | 105.79 | 132.24 | 96.85 | 108.08 | Upgrade
|
| Other Current Assets | 29.4 | 8.3 | 51.13 | 50.71 | 34.31 | Upgrade
|
| Total Current Assets | 6,608 | 6,381 | 6,320 | 5,967 | 5,916 | Upgrade
|
| Property, Plant & Equipment | 4,426 | 4,399 | 4,498 | 4,648 | 4,841 | Upgrade
|
| Long-Term Investments | 70.13 | 69.97 | 112.62 | 185.8 | 308.12 | Upgrade
|
| Other Intangible Assets | 17.13 | 19.15 | 9.95 | 8.79 | 8.9 | Upgrade
|
| Long-Term Deferred Tax Assets | 625.26 | 640.93 | 637.44 | 614.98 | 602.98 | Upgrade
|
| Other Long-Term Assets | 196.6 | 211.48 | 332.96 | 267.07 | 170 | Upgrade
|
| Total Assets | 11,943 | 11,722 | 11,911 | 11,691 | 11,847 | Upgrade
|
| Accounts Payable | 82.17 | 102.46 | 126.5 | 70.86 | 160.84 | Upgrade
|
| Accrued Expenses | - | 139.78 | 139.6 | 124.62 | 125.97 | Upgrade
|
| Short-Term Debt | 35.56 | 32.14 | 77.6 | - | 9.49 | Upgrade
|
| Current Portion of Leases | 19.64 | 17.56 | 17.89 | 16.17 | 16.5 | Upgrade
|
| Current Income Taxes Payable | 11.5 | 62.6 | 99.64 | 71.17 | 67.97 | Upgrade
|
| Current Unearned Revenue | 119.4 | 110.97 | 67.75 | 70.57 | 66.85 | Upgrade
|
| Other Current Liabilities | 499.42 | 263.96 | 274.12 | 202.93 | 239.02 | Upgrade
|
| Total Current Liabilities | 767.68 | 729.45 | 803.09 | 556.31 | 686.65 | Upgrade
|
| Long-Term Leases | 620.34 | 570.23 | 581.18 | 540.27 | 550.18 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 1.3 | 1.66 | - | 0.35 | - | Upgrade
|
| Other Long-Term Liabilities | 27.61 | 1.3 | 2.36 | 3.65 | 1.3 | Upgrade
|
| Total Liabilities | 1,417 | 1,357 | 1,461 | 1,180 | 1,317 | Upgrade
|
| Common Stock | 7,907 | 7,907 | 7,907 | 7,907 | 7,907 | Upgrade
|
| Additional Paid-In Capital | 1,295 | 1,295 | 1,295 | 1,295 | 1,295 | Upgrade
|
| Retained Earnings | 1,450 | 1,348 | 1,346 | 1,370 | 1,360 | Upgrade
|
| Comprehensive Income & Other | -126.18 | -185.86 | -98.18 | -61.13 | -33.04 | Upgrade
|
| Shareholders' Equity | 10,526 | 10,364 | 10,450 | 10,511 | 10,529 | Upgrade
|
| Total Liabilities & Equity | 11,943 | 11,722 | 11,911 | 11,691 | 11,847 | Upgrade
|
| Total Debt | 675.54 | 619.92 | 676.67 | 556.43 | 576.18 | Upgrade
|
| Net Cash (Debt) | 3,490 | 3,322 | 3,618 | 3,524 | 3,479 | Upgrade
|
| Net Cash Growth | 5.08% | -8.19% | 2.65% | 1.31% | 31.91% | Upgrade
|
| Net Cash Per Share | 4.42 | 4.19 | 4.56 | 4.45 | 4.39 | Upgrade
|
| Filing Date Shares Outstanding | 784.53 | 790.74 | 790.74 | 790.74 | 790.74 | Upgrade
|
| Total Common Shares Outstanding | 784.53 | 790.74 | 790.74 | 790.74 | 790.74 | Upgrade
|
| Working Capital | 5,840 | 5,651 | 5,517 | 5,410 | 5,229 | Upgrade
|
| Book Value Per Share | 13.42 | 13.11 | 13.22 | 13.29 | 13.32 | Upgrade
|
| Tangible Book Value | 10,509 | 10,345 | 10,440 | 10,502 | 10,521 | Upgrade
|
| Tangible Book Value Per Share | 13.39 | 13.08 | 13.20 | 13.28 | 13.30 | Upgrade
|
| Buildings | - | 4,249 | 4,095 | 3,546 | 3,518 | Upgrade
|
| Machinery | - | 6,432 | 6,249 | 5,641 | 5,598 | Upgrade
|
| Construction In Progress | - | 77.72 | 155.62 | 1,119 | 1,052 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.